FDA warns Pfizer about Celebrex, Bextra ads

01/13/2005 | Reuters · MarketWatch

The FDA has warned Pfizer that its ads for arthritis drugs Celebrex and Bextra are misleading and fail to include information on adverse side effects of the painkillers. The agency's letter to Pfizer said the advertising campaign made "unsubstantiated effectiveness claims." A Pfizer spokeswoman said the Celebrex ads were no longer running, but she had no comment on the Bextra ads. She added that the company would work with the FDA to explore "appropriate" next steps.

View Full Article in:

Reuters · MarketWatch

Published in Brief:

SmartBrief Job Listings for Media

Job Title Company Location
Full(ish) Stack Engineer (PHP)
Advertising Age
New York, NY
Senior Sales Manager
OnProcess Technology
Affiliate Solutions Consultant
Conversant
Santa Barbara, CA
Ad Operations Manager, The Atlantic
Atlantic Media
Washington, DC
Associate Director of Ad Operations
Opera Mediaworks
New York, NY